Therefore, we conducted literature quality evaluation and meta-analysis of independent studies [31–33] to evaluate the value of serum CA125, CA199, HE4, and their combined application in the diagnosis of ovarian cancer and to provide reliable data for clinical treatment. This evidence concerns the gene WFDC2 and ovarian cancer.